VEGFA and hereditary hemorrhagic telangiectasia: The finding of increased plasma levels of vascular endothelial growth factor (VEGF) in HHT patients provided the basis for targeting VEGF in this syndrome of unbalanced angiogenesis as previously reported [3–5].